Current Perspectives on the Drug Treatment of Neonatal Respiratory Distress Syndrome

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.1, Iss.1, 1999-01, pp. : 19-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome: Current and Experimental Approaches

By Bosma Karen J. Taneja Ravi Lewis James F.

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1255-1282

Adis International

Access to resources Recommend Favorite

Lucinactant in neonatal respiratory distress syndrome: profile report

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Acute respiratory distress syndrome following treatment for babesiosis

By Jr Ryland P Byrd Roy Thomas M

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1541-1542

Informa Healthcare

Access to resources Recommend Favorite

Calfactant: A Review of its Use in Neonatal Respiratory Distress Syndrome

By Onrust S.V. Dooley M. Goa K.L.

Pediatric Drugs, Vol. 1, Iss. 3, 1999-07 ,pp. : 219-243

Adis International

Access to resources Recommend Favorite

Nitric oxide for the treatment of preterm infants with respiratory distress syndrome

By Dani Carlo Pratesi Simone

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 97-103

Informa Healthcare

Access to resources Recommend Favorite